Syncom Formulations (India) Ltd. (SYNCOMF) Share Price Rises 14.61% Today

Published: 28 September 2026 at 9:54:03 AM IST

Syncom Formulations Share Price rose to Rs 22.99 today, up 14.61%, with market capitalisation at Rs 1,885.64 crore. The move places Syncom Formulations (India) Ltd. in focus in today's share market today, even as the supplied data does not establish a company-specific catalyst.

Syncom Formulations Share Price is in the spotlight after the stock rose 14.61% to Rs 22.99 on 28 September 2026, against a previous close of Rs 20.06. The session opened at Rs 20.06, touched a day high of Rs 23.03 and a day low of Rs 20.06, while turnover stood at Rs 4.93 crore and market capitalisation at Rs 1,885.64 crore. On the available data, the price rise is clear, but a company-specific catalyst is not established. For readers tracking Syncom Formulations Share Price Today, the factual trigger is the day's move itself, along with the company's valuation and healthcare sector context. Univest notes that the stock now ranks among the stocks in news on this session based on price action alone.

In Syncom Formulations Share Price news, the focus is on what changed today rather than on any unverified explanation. The stock's rise from Rs 20.06 to Rs 22.99 adds Rs 2.93 per share in one session. That makes the move relevant for investors watching Syncom Formulations Share Price Live, because the update can be read directly from the price, market cap and turnover figures supplied. Univest keeps the discussion grounded in verified numbers so the article stays useful for stock analysis, fundamental analysis and market update tracking.

Syncom Formulations Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 22.99
Previous Close	Rs 20.06
Today's Move	Rs 2.93 (+14.61%)
Open	Rs 20.06
High	Rs 23.03
Low	Rs 20.06
Turnover	Rs 4.93 crore
Market Capitalisation	Rs 1,885.64 crore
Market Cap Category	Small Cap

Syncom Formulations (India) Ltd. (SYNCOMF) rose to Rs 22.99 from the previous close of Rs 20.06, a move of Rs 2.93 or 14.61%. The stock opened at Rs 20.06, reached a high of Rs 23.03, recorded a low of Rs 20.06.

Syncom Formulations Share Price Today shows a clean same-day gain of Rs 2.93, or 14.61%, with the stock closing at Rs 22.99 after opening at Rs 20.06. The intraday range was tight around the opening level, with a day high of Rs 23.03 and a day low of Rs 20.06. The session's turnover was Rs 4.93 crore, which records the traded value for the day. This is the factual price action for Syncom Formulations Share Price, and it confirms a sharp upward move without adding an unverified cause. Univest presents the move as a price rise in the context of today's stock news, not as a forecast or rating.

Syncom Formulations (India) Ltd. (SYNCOMF) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 1,885.64 crore
P/E Ratio	22.05x
P/B Ratio	4.29x
ROE	20.19%
ROCE	26.8%
EPS	Rs 0.91
Book Value Per Share	Rs 4.68
Dividend Yield	0.5%

Syncom Formulations (India) Ltd. (SYNCOMF) fundamental metrics show P/E 22.05x, P/B 4.29x, ROE 20.19%, ROCE 26.8%. These figures provide context only and are not a buy or sell signal.

Syncom Formulations (India) Ltd. has a market capitalisation of Rs 1885.64 crore and falls in the Small Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 22.05x, P/B at 4.29x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 20.19% and ROCE of 26.8%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 0.91, book value per share of Rs 4.68, dividend yield of 0.5%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 32.87x, median ROE of 11.48%, median ROCE of 13.17%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	22.05x
Benchmark Median P/E	32.87x
Benchmark Average P/E	49.63x
Benchmark P/E Range	3.46x to 735.85x
Company P/B Ratio	4.29x
Benchmark Median P/B	2.85x
Company ROE	20.19%
Benchmark Median ROE	11.48%
Company ROCE	26.8%
Benchmark Median ROCE	13.17%
Company Market Capitalisation	Rs 1,885.64 crore
Benchmark Median Market Cap	Rs 732.57 crore

Syncom Formulations (India) Ltd. (SYNCOMF) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Syncom Formulations (India) Ltd. (SYNCOMF) has a P/E ratio of 22.05x, which is below the benchmark median of 32.87x, a difference of -32.92%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Syncom Formulations (India) Ltd. (SYNCOMF) has a ROE of 20.19%, which is above the benchmark median of 11.48%, a difference of +75.87%. Syncom Formulations (India) Ltd. (SYNCOMF) has a ROCE of 26.8%, which is above the benchmark median of 13.17%, a difference of +103.49%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sun Pharmaceutical Industries Ltd.	SUNPHARMA	4,44,716.74	36.77	5.14	14.85	19.11
Divi's Laboratories Ltd.	DIVISLAB	2,55,115.31	87.22	14.44	16.19	21.51
Torrent Pharmaceuticals Ltd.	TORNTPHARM	1,89,613.38	86.94	21.13	26.76	19.27
Zydus Lifesciences Ltd.	ZYDUSLIFE	1,19,899.96	26.57	4.45	19.69	21.39
Cipla Ltd.	CIPLA	1,12,875.68	33.49	3.21	11.83	16

Syncom Formulations (India) Ltd. (SYNCOMF) has a P/E ratio of 22.05x compared with the displayed peer median of 36.77x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 20.19% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 26.8% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Syncom Formulations (India) Ltd. (SYNCOMF) has a market capitalisation of Rs 1,885.64 crore. Among the 5 peers shown, 5 have a larger market capitalisation.

Why Investors Are Watching Syncom Formulations

• Syncom Formulations Share Price rose 14.61% today to Rs 22.99.
• The stock moved up Rs 2.93 from the previous close of Rs 20.06.
• Market capitalisation stands at Rs 1,885.64 crore.
• P/E is 22.05, P/B is 4.29, ROE is 20.19% and ROCE is 26.80%.
• In the same industry benchmark, the company's P/E is below the median of 32.87 and its ROE and ROCE are above the median levels.

About Syncom Formulations (India) Ltd.

Syncom Formulations (India) Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The company description supplied in the data is limited, so the reliable framing here is based on its listed industry and the financial metrics attached to the stock. As a pharmaceuticals business, it belongs to a segment where investors often compare valuation, profitability and market capitalisation against other domestic listed peers. The current data shows Syncom Formulations with a market cap of Rs 1,885.64 crore, a P/E of 22.05 and a P/B of 4.29, which makes its stock performance relevant not just for today's price rise but also for wider company overview and financial analysis reading. Univest uses these figures to help readers place the company within the Indian stock market healthcare universe.

The share price movement today does not change the business description, but it does bring Syncom Formulations Share Price back into focus for readers tracking stock updates, company news and market update articles. When new company-specific information arrives, the same stock page can be used to review the next move in context.

Track Syncom Formulations Share Price on Univest

Use Syncom Formulations (India) Ltd. (SYNCOMF) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

You can track Syncom Formulations Share Price on Univest for live share price updates, stock news, fundamental ratios, shareholding pattern, 52-week levels and market insights. Univest also helps readers follow Syncom Formulations Stock News, Syncom Formulations Share Price Today and broader Syncom Formulations Stock Analysis in one place, so the current move can be compared with future updates using the same verified market data.

For investors who follow market news and share market today developments, the stock page is a practical way to keep Syncom Formulations Share Price under review alongside financial results, peer comparison and sector analysis. Univest presents the figures in a structured format so the reader can return when fresh stock updates appear.

Frequently Asked Questions

Why did Syncom Formulations Share Price rise today?

Ans. The supplied data confirms a 14.61% rise to Rs 22.99, but it does not establish a company-specific catalyst. The move is visible in today's price action, previous close, open, high, low and turnover figures.

What is Syncom Formulations Share Price today?

Ans. Syncom Formulations Share Price today is Rs 22.99. It gained Rs 2.93, or 14.61%, from the previous close of Rs 20.06 and closed near the session high of Rs 23.03.

What is the market cap of Syncom Formulations?

Ans. The market capitalisation of Syncom Formulations is Rs 1,885.64 crore. That figure places the company above the same-industry median market cap of Rs 732.57 crore, based on the supplied benchmark set.

How is Syncom Formulations valued on earnings and book value?

Ans. Syncom Formulations has a P/E ratio of 22.05 and a P/B ratio of 4.29. Its EPS is Rs 0.91 and book value is Rs 4.68, giving readers a direct valuation reference.

What do ROE and ROCE show for Syncom Formulations?

Ans. ROE is 20.19% and ROCE is 26.80%. These figures indicate the company's reported profitability and capital efficiency, and both sit above the same-industry median and average levels supplied in the benchmark.

How does Syncom Formulations compare with peers?

Ans. Compared with listed peers in pharmaceuticals, Syncom Formulations has a lower P/E than Sun Pharma, Divi's Laboratories and Torrent Pharmaceuticals. Its ROE and ROCE are also competitive against several of the supplied peers.

What is the dividend yield for Syncom Formulations?

Ans. Syncom Formulations has a dividend yield of 0.5%. This is a factual yield measure based on the supplied data and should be read alongside the current share price and other valuation ratios.

Should investors track Syncom Formulations Share Price on Univest?

Ans. Investors tracking Syncom Formulations Share Price can use Univest to monitor live price updates, fundamentals, shareholding pattern and sector context. The platform keeps the stock page aligned with verified market data and related stock news.